Copyright
©The Author(s) 2015.
World J Gastroenterol. Feb 28, 2015; 21(8): 2323-2335
Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2323
Published online Feb 28, 2015. doi: 10.3748/wjg.v21.i8.2323
Figure 5 Profilin-1 silencing regulates the expression of integrin β1 and its downstream molecular targets.
A and B: Expression of integrin β1 protein and mRNA was detected by Western blot and quantitative real-time polymerase chain reaction analyses, respectively; C: The effect of profilin-1 (PFN1) knockdown on its downstream targets in the focal adhesion kinase (FAK) signaling pathway. The quantity of PFN1 was normalized against that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and the phosphorylation of other proteins was normalized against the respective total protein. All results were obtained from three independent experiments. aP < 0.05, bP < 0.01 vs other groups. ERK: Extracellular-regulated kinase; mTOR: Mammalian target of rapamycin; PI3K: Phosphatidylinositol 3-kinase; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; NC: Negative control; Si: Silencing.
-
Citation: Cheng YJ, Zhu ZX, Zhou JS, Hu ZQ, Zhang JP, Cai QP, Wang LH. Silencing profilin-1 inhibits gastric cancer progression
via integrin β1/focal adhesion kinase pathway modulation. World J Gastroenterol 2015; 21(8): 2323-2335 - URL: https://www.wjgnet.com/1007-9327/full/v21/i8/2323.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i8.2323